Accepted answer
Your reasoning is correct. There is no withdrawal syndrome and no receptor-rebound mechanism that a taper prevents. The pharmacokinetics mean that abrupt cessation is already a taper. The case for a deliberate dose taper is behavioural and, in one specific sense, dose-response related. That is a real case, just not the one usually made for it.
The half-life argument, worked
Semaglutide has an elimination half-life of approximately one week. After the last dose, plasma concentration falls geometrically:
Week 0 (last dose): 100% of steady-state peak contribution
Week 1: 50%
Week 2: 25%
Week 3: 12.5%
Week 4: 6.3%
Week 5: 3.1%
Week 6: 1.6%
By week five you are below about 3% of your prior exposure, and the decline through weeks one to four is smooth. Compare that to a deliberate stepwise taper from 2.4 to 1.7 to 1.0 to 0.5 mg with four weeks at each step: your exposure spends longer at intermediate levels, but it never encounters a discontinuity in either case. There is no cliff for a taper to smooth.
Tirzepatide behaves similarly with a half-life around five days, so the same argument applies with the timeline compressed by roughly 30%.
Contrast with the drug classes where tapering is genuinely mandatory: beta blockers where receptor upregulation during treatment produces a hypersensitivity rebound, benzodiazepines and alcohol where GABAergic adaptation produces a withdrawal syndrome with real morbidity, corticosteroids where the adrenal axis is suppressed and cannot resume instantly. GLP-1 receptor agonists have none of these features. There is no documented withdrawal syndrome, no rebound hyperphagia beyond a return to pre-treatment appetite, and no axis to recover.
What a taper does do
Three things, all worth having:
- It converts an event into a process. The behavioural task after stopping is enormous: eating deliberately at a maintenance intake without the appetite suppression that made it easy. A taper gives you three to four months of gradually increasing difficulty in which to build that capability, rather than presenting the whole difficulty in week four. Every step down is a small, survivable rehearsal.
- It gives you a diagnostic at each step. If you step from 2.4 to 1.7 mg and weight holds for six weeks, you have learned something valuable: that 1.7 mg is sufficient for maintenance in you. If it does not hold, you have learned that at low cost and can step back up. Abrupt cessation gives you a single data point and no way to find the minimum effective maintenance dose.
- It exploits the dose-response curve. The relationship between dose and appetite effect is continuous, not binary. A partial dose gives a partial effect. If your goal is maintenance rather than further loss, a partial effect may be exactly enough, and a taper is how you find out where that point is.
What I would do in your position
Not a taper to zero, unless something forces it. A taper toward the lowest dose that maintains, and then hold there:
2.4 mg -> hold weight stable for 8-12 weeks first
2.4 -> 1.7 mg, observe 6-8 weeks (about 6 half-lives, so the new steady state is established)
1.7 -> 1.0 mg, observe 6-8 weeks
1.0 -> 0.5 mg, observe 6-8 weeks
Stop at whichever step weight begins a sustained rise, step back up one level, hold.
Two mechanics matter. First, wait long enough at each step: you need roughly five half-lives, so five to six weeks, before the new exposure is stable, and then two or three weeks of trend data on top. Judging a step at two weeks tells you nothing. Second, judge on rolling weekly averages and waist rather than daily weight, or fluid noise will make every step look like a failure.
If the goal genuinely is zero, for cost, pregnancy planning, side effects or preference, then the taper's value is entirely in point 1 above, and a shorter taper of two steps over eight to ten weeks captures most of that. There is no pharmacological penalty for stopping abruptly and no reason to feel you have done something wrong if circumstances force it.
Whichever route, this is a conversation to have with whoever prescribes for you rather than something to arrange around them, particularly if you are on it for a diabetes or cardiovascular indication rather than for weight, where stopping has consequences beyond the scale.
7Framing the taper as a search for the minimum maintenance dose rather than as an exit ramp is a much more useful way to think about it. – Dr_Priya_Raghunathan 5 months ago 6Five to six weeks per step is longer than most taper schedules allow, and the reason given here is the correct one. – charge_state_3 3 months ago add a comment